Evidence map›Paper›PMID 39221168›Full record

ArticleBiofilm2024

Global challenges and microbial biofilms: Identification of priority questions in biofilm research, innovation and policy.

Tom Coenye, Merja Ahonen, Skip Anderson, Miguel Cámara, Parvathi Chundi, Matthew Fields, Ines Foidl, Etienne Z Gnimpieba, Kristen Griffin, Jamie Hinks and 11 more

Abstract read
In one paragraph

Article in Biofilm, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University, Belgium.
Merja AhonenSatakunta University of Applied Sciences, Finland.
Skip AndersonCenter for Biofilm Engineering, Montana State University, Bozeman, MT, USA.
Miguel CámaraNational Biofilms Innovation Centre, University of Nottingham Biodiscovery Institute, School of Life Sciences, University of Nottingham, Nottingham, UK.
Parvathi ChundiUniversity of Nebraska, Omaha, NE, USA.
Matthew FieldsCenter for Biofilm Engineering, Montana State University, Bozeman, MT, USA.
Ines FoidlNational Biofilms Innovation Centre, School of Physics and Astronomy, University of Edinburgh, Edinburgh, UK.
Etienne Z GnimpiebaUniversity of South Dakota, Vermillion, SD, USA.
Kristen GriffinCenter for Biofilm Engineering, Montana State University, Bozeman, MT, USA.
Jamie HinksNanyang Technological University, Singapore.
Anup R LokaUniversity of Nebraska, Omaha, NE, USA.
Carol LushboughUniversity of South Dakota, Vermillion, SD, USA.
Cait MacPheeNational Biofilms Innovation Centre, School of Physics and Astronomy, University of Edinburgh, Edinburgh, UK.
Natasha NaterNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.
Rasmita RavalNational Biofilms Innovation Centre, Open Innovation Hub for Antimicrobial Surfaces, Department of Chemistry, University of Liverpool, Liverpool, UK.
Jo Slater-JefferiesNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.
Pauline TeoNanyang Technological University, Singapore.
Sandra WilksNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.
Maria YungSingapore Centre for Environmental Life Sciences Engineering (SCELSE), Singapore.
Biofilm Priority Questions Exercise Participants
Jeremy S WebbNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.

Funding

Wichozani-A Healthy Lifestyle for Rural American Indian Youth through Cultural and Physical Activities: A Community-Based Participatory Research StudyP20GM103443 · NIGMS · UNIVERSITY OF SOUTH DAKOTA · PI Victor Chester Huber · 2012 to 2026
$58.1M
NIGMS NIH HHS P20 GM103443
6 · The paper itself

Abstract

Priority question exercises are increasingly used to frame and set future research, innovation and development agendas. They can provide an important bridge between the discoveries, data and outputs generated by researchers, and the information required by policy makers and funders. Microbial biofilms present huge scientific, societal and economic opportunities and challenges. In order to identify key priorities that will help to advance the field, here we review questions from a pool submitted by the international biofilm research community and from practitioners working across industry, the environment and medicine. To avoid bias we used computational approaches to group questions and manage a voting and selection process. The outcome of the exercise is a set of 78 unique questions, categorized in six themes: (i) Biofilm control, disruption, prevention, management, treatment (13 questions); (ii) Resistance, persistence, tolerance, role of aggregation, immune interaction, relevance to infection (10 questions); (iii) Model systems, standards, regulatory, policy education, interdisciplinary approaches (15 questions); (iv) Polymicrobial, interactions, ecology, microbiome, phage (13 questions); (v) Clinical focus, chronic infection, detection, diagnostics (13 questions); and (vi) Matrix, lipids, capsule, metabolism, development, physiology, ecology, evolution environment, microbiome, community engineering (14 questions). The questions presented are intended to highlight opportunities, stimulate discussion and provide focus for researchers, funders and policy makers, informing future research, innovation and development strategy for biofilms and microbial communities.

Identifiers

PMID39221168
PMCPMC11364012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.